This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively (NICE)
Diabetes News
Tag: NICE
Dapagliflozin with insulin for treating type 1 diabetes
Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for treating type 1 diabetes not controlled by insulin therapy alone in adults with a body mass index (BMI) of at least 27 kg/m2 (NICE)
Dapagliflozin with insulin for treating type 1 diabetes
Recommendations (NICE)
Surveillance proposal consultation document
2019 surveillance of 4 diabetes guidelines (NICE)
Type 2 diabetes mellitus: medicines optimisation priorities
This document summarises the evidence base on type 2 diabetes mellitus: medicines optimisation priorities. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance
Medical devices: information for users and patients
Including blood glucose meters (NICE)
Managing hypertension in people of African origin with diabetes: Evaluation of adherence to NICE Guidelines
This study provides insight into adherence to NICE guidance for managing hypertension in African origin patients with diabetes. Further work should be done to explore the effects of hypertension in this ethnic group and if there is a need for a more refined management guideline (Primary Care Diabetes)
NICE impact diabetes
This report considers how NICE’s evidence-based guidance can contribute to improvements in the prevention and management of diabetes
Type 2 diabetes: prevention in people at high risk
This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition (NICE)
Obese, overweight with risk factors: liraglutide (Saxenda)
This evidence summary discusses 4 randomised controlled trials (RCTs) in adults who were obese or overweight (BMI 27 kg/m2 or above) with a variety of weight-related comorbidities including dyslipidaemia, hypertension, type 2 diabetes and obstructive sleep apnoea (NICE)
Type 2 diabetes prevention. Standing committee C update
Addendum consultation (NICE)
Type 2 diabetes in adults: management
This updated guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications (NICE)
Neuropathic pain in adults: pharmacological management in non-specialist settings
This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living (NICE)
Dapagliflozin in triple therapy for treating type 2 diabetes
Evidence-based recommendations on dapagliflozin (Forxiga) given with 2 other drugs for treating type 2 diabetes in adults (NICE)
Diabetes (type 1 and type 2) in children and young people: diagnosis and management
This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends strict targets for blood glucose control to reduce the long-term risks associated with diabetes (NICE)
UrgoStart for chronic wounds
The technology described in this briefing is the UrgoStart wound dressing. It is used to treat chronic wounds such as diabetic foot ulcers, pressure ulcers or venous leg ulcers, as well as non-healing acute wounds (NICE)
Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales
In over three-quarters of patients, anti-diabetic drugs are being prescribed per NICE guidance. When insulin is being used earlier than recommended, there appears to be a need for urgent and rapid glycaemic control (Pharmacoepidemiology and Drug Safety)
Type 1 diabetes in adults: diagnosis and management
This guideline covers the care and treatment of adults (aged 18 and over) with type 1 diabetes (NICE)
Type 2 diabetes in adults: management
This guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications (NICE)
Diabetes in children and young people
This quality standard covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18 (NICE)
Glycosmedia is also available as an App: